AR231134A1 - Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina - Google Patents

Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina

Info

Publication number
AR231134A1
AR231134A1 AR287966A AR28796681A AR231134A1 AR 231134 A1 AR231134 A1 AR 231134A1 AR 287966 A AR287966 A AR 287966A AR 28796681 A AR28796681 A AR 28796681A AR 231134 A1 AR231134 A1 AR 231134A1
Authority
AR
Argentina
Prior art keywords
tiazolina
sulfamoilfenil
fenilimino
aciloxi
hidroxi
Prior art date
Application number
AR287966A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AR231134A1 publication Critical patent/AR231134A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR287966A 1980-12-30 1981-12-28 Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina AR231134A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803049460 DE3049460A1 (de) 1980-12-30 1980-12-30 "thiazolinderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Publications (1)

Publication Number Publication Date
AR231134A1 true AR231134A1 (es) 1984-09-28

Family

ID=6120529

Family Applications (2)

Application Number Title Priority Date Filing Date
AR287966A AR231134A1 (es) 1980-12-30 1981-12-28 Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina
AR291445A AR231978A1 (es) 1980-12-30 1982-11-30 Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-3-alquil(c-c)-tiazolina y derivados de 4-(sulfamoilfenil)-2-(hidroxi o aciloxi-fenilimino)-tiazolidin-4-ol para su uso exclusivo en dicho procedimiento

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR291445A AR231978A1 (es) 1980-12-30 1982-11-30 Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-3-alquil(c-c)-tiazolina y derivados de 4-(sulfamoilfenil)-2-(hidroxi o aciloxi-fenilimino)-tiazolidin-4-ol para su uso exclusivo en dicho procedimiento

Country Status (17)

Country Link
US (1) US4421757A (fr)
EP (1) EP0055458B1 (fr)
JP (1) JPS57134472A (fr)
KR (1) KR830007601A (fr)
AR (2) AR231134A1 (fr)
AT (1) ATE11778T1 (fr)
AU (1) AU542670B2 (fr)
CA (1) CA1173836A (fr)
DE (2) DE3049460A1 (fr)
DK (1) DK581181A (fr)
ES (5) ES508293A0 (fr)
FI (1) FI814175L (fr)
HU (1) HU184976B (fr)
IE (1) IE52259B1 (fr)
IL (1) IL64653A (fr)
NO (1) NO154551B (fr)
ZA (1) ZA818968B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761422A (en) * 1986-11-20 1988-08-02 Lusofarmaco Istituto Lusofarmaco D'italia Spa (2-amino-4-aryl-thiazole-5-yl)ethanols and their derivatives having diuretic activity and methods for preparing the same
US6353006B1 (en) 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
EP1144396A2 (fr) * 1999-01-14 2001-10-17 Bayer Corporation Heterocycles 2-arylimino substitues et compositions les contenant, utilisables comme agents de liaison des recepteurs de progesterone
FR2796643B1 (fr) * 1999-07-22 2005-04-29 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
KR100509401B1 (ko) 1999-09-14 2005-08-22 시오노기세이야쿠가부시키가이샤 2-이미노-1,3-티아진 유도체
US7271195B2 (en) 2003-06-10 2007-09-18 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
BRPI0411275A (pt) * 2003-06-10 2006-08-01 Kalypsys Inc compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
SE7700436L (sv) * 1976-01-17 1977-07-18 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning
DE2926771A1 (de) * 1979-07-03 1981-01-15 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES8305342A1 (es) 1983-04-01
ES518272A0 (es) 1983-09-01
FI814175L (fi) 1982-07-01
IL64653A (en) 1985-09-29
ATE11778T1 (de) 1985-02-15
AU7906881A (en) 1982-07-08
AR231978A1 (es) 1985-04-30
ES518271A0 (es) 1984-02-16
KR830007601A (ko) 1983-11-04
ES8402829A1 (es) 1984-02-16
DE3049460A1 (de) 1982-07-29
CA1173836A (fr) 1984-09-04
ES8308551A1 (es) 1983-09-01
JPS57134472A (en) 1982-08-19
NO814468L (no) 1982-07-01
NO154551B (no) 1986-07-07
IL64653A0 (en) 1982-03-31
ES8308549A1 (es) 1983-09-01
ES518273A0 (es) 1983-09-01
EP0055458A3 (en) 1982-10-20
DK581181A (da) 1982-07-01
ES8308550A1 (es) 1983-09-01
US4421757A (en) 1983-12-20
IE52259B1 (en) 1987-08-19
HU184976B (en) 1984-11-28
DE3168978D1 (en) 1985-03-28
ES518274A0 (es) 1983-09-01
ZA818968B (en) 1982-11-24
IE813057L (en) 1982-06-30
EP0055458A2 (fr) 1982-07-07
EP0055458B1 (fr) 1985-02-13
ES508293A0 (es) 1983-04-01
AU542670B2 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
ES491687A0 (es) Procedimiento para la obtencion de derivados de vinil-3 ce- falosporina
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
AR231134A1 (es) Procedimiento para obtener derivados de 4-(sulfamoilfenil)-2-(hidroxi-o aciloxi-fenilimino)-tiazolina
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
AR231289A1 (es) Procedimiento para preparar derivados de quinolil-4-1-piperidilo-4-2-etanol o quinolil-4-1-piperidil-4-3-propanol
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
ES504787A0 (es) Procedimiento para la obtencion de derivados de diaril-imi- dazol
ES500892A0 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
AR227410A1 (es) Procedimiento para obtener derivados de 2-(fenoxi o feniltio)-5-nitrobenzaldehido
ES502649A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES500761A0 (es) Procedimiento perfeccionado para la fabricacion de derivadosde la quinolina
ES505206A0 (es) Procedimiento para la obtencion de derivados de 1-azolil-bu-tano fluorados
ES499421A0 (es) Procedimiento para preparar derivados de indano
ES493591A0 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
ES497444A0 (es) Procedimiento para la obtencion de derivados de 2-amino-eta-nol
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
ES500267A0 (es) Procedimiento para la obtencion de compuestos de isotiazoli-lo
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina
AR229111A1 (es) Procedimiento para la preparacion de nicotinatos de 4-(fenilalquiloxi 4-sustituido)fenilalquilo
AR227341A1 (es) Procedimiento para preparar derivados de bis-aminometil-antraquinona
AR231631A1 (es) Procedimiento para elaborar nuevos derivados de 1-(2-(carbamoil-hidroxifenoxi)-etilamino)-3-fenoxi-2-propanol
ES500306A0 (es) Procedimiento para la preparacion de nuevos derivados este- roide-espiro-oxatiazolidinos